Drug Shortage Report for GLUCOPHAGE
Report ID | 76402 |
Drug Identification Number | 02162849 |
Brand name | GLUCOPHAGE |
Common or Proper name | Glucophage |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE |
Strength(s) | 850MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A10BA |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-03-28 |
Actual start date | |
Estimated end date | 2019-05-03 |
Actual end date | 2019-04-26 |
Shortage status | Resolved |
Updated date | 2019-07-19 |
Company comments | Delay in production |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-07-19 | French | Compare |
v5 | 2019-07-19 | English | Compare |
v4 | 2019-03-29 | English | Compare |
v3 | 2019-02-20 | French | Compare |
v2 | 2019-02-20 | English | Compare |
v1 | 2019-02-20 | English | Compare |
Showing 1 to 6 of 6